全文获取类型
收费全文 | 947篇 |
免费 | 49篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 14篇 |
妇产科学 | 22篇 |
基础医学 | 125篇 |
口腔科学 | 5篇 |
临床医学 | 75篇 |
内科学 | 80篇 |
皮肤病学 | 24篇 |
神经病学 | 73篇 |
特种医学 | 12篇 |
外科学 | 283篇 |
综合类 | 5篇 |
预防医学 | 54篇 |
眼科学 | 13篇 |
药学 | 98篇 |
肿瘤学 | 96篇 |
出版年
2023年 | 4篇 |
2022年 | 6篇 |
2021年 | 9篇 |
2020年 | 12篇 |
2019年 | 18篇 |
2018年 | 15篇 |
2017年 | 9篇 |
2016年 | 14篇 |
2015年 | 19篇 |
2014年 | 14篇 |
2013年 | 24篇 |
2012年 | 44篇 |
2011年 | 58篇 |
2010年 | 23篇 |
2009年 | 26篇 |
2008年 | 46篇 |
2007年 | 43篇 |
2006年 | 39篇 |
2005年 | 54篇 |
2004年 | 39篇 |
2003年 | 38篇 |
2002年 | 39篇 |
2001年 | 20篇 |
2000年 | 37篇 |
1999年 | 28篇 |
1998年 | 18篇 |
1997年 | 14篇 |
1996年 | 27篇 |
1995年 | 15篇 |
1994年 | 11篇 |
1993年 | 10篇 |
1992年 | 30篇 |
1991年 | 38篇 |
1990年 | 20篇 |
1989年 | 21篇 |
1988年 | 23篇 |
1987年 | 19篇 |
1986年 | 16篇 |
1985年 | 16篇 |
1984年 | 10篇 |
1983年 | 7篇 |
1982年 | 3篇 |
1981年 | 3篇 |
1980年 | 2篇 |
1979年 | 6篇 |
1978年 | 7篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1974年 | 2篇 |
排序方式: 共有998条查询结果,搜索用时 15 毫秒
101.
102.
103.
Verraedt E Braem A Chaudhari A Thevissen K Adams E Van Mellaert L Cammue BP Duyck J Anné J Vleugels J Martens JA 《International journal of pharmaceutics》2011,419(1-2):28-32
Amorphous microporous silica (AMS) serving as a reservoir for controlled release of a bioactive agent was applied in the open porosity of a titanium coating on a Ti-6Al-4V metal substrate. The pores of the AMS emptied by calcination were loaded with chlorhexidine diacetate (CHX) via incipient wetness impregnation with CHX solution, followed by solvent evaporation. Using this CHX loaded AMS system on titanium substrate sustained release of CHX into physiological medium was obtained over a 10 day-period. CHX released from the AMS coating was demonstrated to be effective in killing planktonic cultures of the human pathogens Candida albicans and Staphylococcus epidermidis. This surface modification of titanium bodies with AMS controlled release functionality for a bioactive compound potentially can be applied on dental and orthopaedic implants to abate implant-associated microbial infection. 相似文献
104.
Li Z Zhan P Naesens L Vanderlinden E Liu A Du G De Clercq E Liu X 《Chemical biology & drug design》2012,79(6):1018-1024
The diversity-oriented chemistry synthesis together with the random screening approach has permitted the discovery and optimization of novel antiviral lead compounds. In this paper, a series of novel 5-substituted-2-(4-substituted phenyl)-1,3-benzoxazoles was synthesized and evaluated for their in vitro anti-influenza A virus and anti-influenza B virus activity. The activity was monitored by the MTS assay in the Madin-Darby canine kidney cells. Compound 7h showed excellent inhibitory activity and selective index against A/H3N2 (EC(50) = 37.03 μm, SI > 5), which were all higher than that of the reference drug oseltamivir (EC(50) > 59.00 μm, SI > 1). However, no compound displays inhibitory activity against influenza B virus. 相似文献
105.
106.
Ebun A Abarshi Michael A Echteld Lieve Van den Block G�� A Donker Luc Deliens Bregje D Onwuteaka-Philipsen 《The British journal of general practice》2011,61(587):e371-e378
Background
Recognising patients who will die in the near future is important for adequate planning and provision of end-of-life care. GPs can play a key role in this.Aim
To explore the following questions: How long before death do GPs recognise patients likely to die in the near future? Which patient, illness, and care-related characteristics are related to such recognition? How does recognising death in the near future, before the last week of life, relate to care in during this period?Design and setting
One-year follow-back study via a surveillance GP network in the Netherlands.Method
Registration of demographic and care-related characteristics.Results
Of 252 non-sudden deaths, 70% occurred in the home or care home and 30% in hospital. GP recognition of death in the near future was absent in 30%, and occurred prior to the last month in 15%, within the last month in 19%, and in the last week in 34%. Logistic regression analyses showed cancer and low functional status were positively associated with death in the near future; cancer and discussing palliative care options were positively associated with recognising death in the near future before the last week of life. Recognising death in the near future before patients’ last week of life was associated with fewer hospital deaths, more GP–patient contacts in the last week, more deaths in a preferred place, and more-frequent GP–patient discussions about specific topics in the last 7 days of life.Conclusion
Recognising death in the near future precedes several aspects of end-of-life care. The proportion in whom death in the near future is never recognised is large, suggesting GPs could be assisted in this process through training and implementation of care protocols that promote timely recognition of the dying phase. 相似文献107.
Lieve Vd Shafer LA Mayanja BN Whitworth JA Grosskurth H 《Tropical medicine & international health : TM & IH》2007,12(8):920-928
OBJECTIVE: To investigate the effect of pregnancy on HIV disease progression and survival among HIV-infected women in rural Uganda, prior to the introduction of anti-retroviral therapy (ART). METHODS: From a clinical cohort established in 1990, we selected records from HIV-infected women of reproductive age. We conducted two analyses: (1) all HIV-infected cases contributing to analysis of CD4 decline, using a linear regression model with random intercepts and slopes; (b) incident cases with known date of seroconversion contributed to analyses of median time to CD4 <200 cells/microl, AIDS and death. RESULTS: A total of 139 women were included in the analysis of CD4 decline. Women who subsequently became pregnant had higher CD4 counts at enrolment and had a slower CD4 decline than those who did not become pregnant. In women who became pregnant, CD4 decline was faster after pregnancy than before (P < 0.0001). The survival analyses showed no significant differences between women who became pregnant and those who did not with respect to median time to CD4 count <200, AIDS or death. CONCLUSIONS: The initial comparative immunological advantage possessed by fertile women before they become pregnant is subsequently lost as a result of their pregnancy. Women should be informed about the potential negative effect of pregnancy on their immunological status and should be offered contraception. In resource-limited settings, women determined to become pregnant should be given priority for ART if eligible. 相似文献
108.
109.
Lieve Van den Block Reginald Deschepper Johan Bilsen Nathalie Bossuyt Viviane Van Casteren Luc Deliens 《BMC public health》2009,9(1):79
Background
This study compares prevalence and types of medical end-of-life decisions between the Dutch-speaking and French-speaking communities of Belgium. This is the first nationwide study that can make these comparisons and the first measurement after implementation of the euthanasia law (2002). 相似文献110.
Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications 总被引:2,自引:0,他引:2
Debruyne EN Delanghe JR 《Clinica chimica acta; international journal of clinical chemistry》2008,395(1-2):19-26
Hepatocellular carcinoma is the 5th most common cancer in the world. Prognosis for this disease is poor since hepatocellular carcinoma is mostly diagnosed at an advanced stage. Serum alpha-fetoprotein (AFP) is one of the most common diagnostic markers for hepatocellular carcinoma. However, its diagnostic value is more and more questioned. Therefore, research has focussed on AFP related parameters (AFP mRNA and AFP glycoforms). The aim of this paper is to review the present knowledge on AFP and its related parameters in diagnosing and monitoring HCC. AFP related parameters can be arranged in two types: AFP mRNA and AFP glycoforms. AFP mRNA is a potentially prognostic marker and AFP mRNA assays are based on PCR techniques. The AFP glycoforms have diagnostic potential and assays are based on isoelectric focussing and lectin affinity electrophoretic methods. Up to now the diagnostic use of the AFP related parameters is limited. Although some of them are recommended as a complementary test, they cannot (yet) replace serum AFP as the golden standard of diagnostic markers for hepatocellular carcinoma. 相似文献